Nurix Therapeutics, Inc.
US ˙ NasdaqGM ˙ US67080M1036

Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Group L P Column. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Group L P Column telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:NGM / NGM Biopharmaceuticals, Inc. Director, 10% Owner 1,000
US:NRIX / Nurix Therapeutics, Inc. 10% Owner 48,406
10% Owner 99,155
US:IMDZ / Immune Design Corp. 10% Owner 0
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Group L P Column. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Pembelian Orang Dalam NRIX / Nurix Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di NRIX / Nurix Therapeutics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

NRIX / Nurix Therapeutics, Inc. Insider Trades
Penjualan Orang Dalam NRIX / Nurix Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di NRIX / Nurix Therapeutics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

NRIX / Nurix Therapeutics, Inc. Insider Trades
Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Group L P Column sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
J - Other 1,000 1,000
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -44,000 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -15,000 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -100,000 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -100,000 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -1,298,908 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -1,298,908 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -2,265,758 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -968,990 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -858,035 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -11,103,333 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -90,442 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -2,650,177 0 -100.00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -949,862 0 -100.00
2023-11-17 2023-11-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5,840 949,862 0.62 0.62 3,627 589,959
2023-11-17 2023-11-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 16,791 944,022 1.81 0.71 11,880 667,896
2023-11-17 2023-11-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5,840 949,862 0.62 0.62 3,627 589,959
2023-11-17 2023-11-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 16,791 944,022 1.81 0.71 11,880 667,896
2023-11-17 2023-11-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5,840 949,862 0.62 0.62 3,627 589,959
2023-11-17 2023-11-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 16,791 944,022 1.81 0.71 11,880 667,896
2023-02-01 2023-01-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 176,730 927,231 23.55 5.00 883,403 4,634,857
2023-02-01 2023-01-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7,542 750,501 1.02 5.00 37,707 3,752,205
2023-02-01 2023-01-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 176,730 927,231 23.55 5.00 883,403 4,634,857
2023-02-01 2023-01-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7,542 750,501 1.02 5.00 37,707 3,752,205
2023-02-01 2023-01-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 176,730 927,231 23.55 5.00 883,403 4,634,857
2023-02-01 2023-01-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7,542 750,501 1.02 5.00 37,707 3,752,205
2023-01-25 2023-01-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 9,900 742,959 1.35 5.00 49,494 3,714,349
2023-01-25 2023-01-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 9,900 742,959 1.35 5.00 49,494 3,714,349
2023-01-25 2023-01-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 9,900 742,959 1.35 5.00 49,494 3,714,349
2023-01-23 2023-01-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 500 733,059 0.07 5.00 2,498 3,662,363
2023-01-23 2023-01-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37,639 732,559 5.42 5.00 188,105 3,661,037
2023-01-23 2023-01-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 500 733,059 0.07 5.00 2,498 3,662,363
2023-01-23 2023-01-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37,639 732,559 5.42 5.00 188,105 3,661,037
2023-01-23 2023-01-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 500 733,059 0.07 5.00 2,498 3,662,363
2023-01-23 2023-01-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37,639 732,559 5.42 5.00 188,105 3,661,037
2023-01-17 2023-01-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5,378 694,920 0.78 4.95 26,603 3,437,491
2023-01-17 2023-01-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5,378 694,920 0.78 4.95 26,603 3,437,491
2023-01-17 2023-01-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5,378 694,920 0.78 4.95 26,603 3,437,491
2023-01-12 2023-01-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 209,000 689,542 43.49 4.76 994,840 3,282,220
2023-01-12 2023-01-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 100,070 480,542 26.30 4.84 484,519 2,326,688
2023-01-12 2023-01-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 209,000 689,542 43.49 4.76 994,840 3,282,220
2023-01-12 2023-01-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 100,070 480,542 26.30 4.84 484,519 2,326,688
2023-01-12 2023-01-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 209,000 689,542 43.49 4.76 994,840 3,282,220
2023-01-12 2023-01-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 100,070 480,542 26.30 4.84 484,519 2,326,688
2022-12-14 2022-12-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 300 380,472 0.08 4.98 1,493 1,893,495
2022-12-14 2022-12-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 300 380,472 0.08 4.98 1,493 1,893,495
2022-12-14 2022-12-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 300 380,472 0.08 4.98 1,493 1,893,495
2022-11-23 2022-11-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4,330 380,172 1.15 5.00 21,646 1,900,518
2022-11-23 2022-11-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 35,997 375,842 10.59 5.00 179,942 1,878,759
2022-11-23 2022-11-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4,330 380,172 1.15 5.00 21,646 1,900,518
2022-11-23 2022-11-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 35,997 375,842 10.59 5.00 179,942 1,878,759
2022-11-23 2022-11-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4,330 380,172 1.15 5.00 21,646 1,900,518
2022-11-23 2022-11-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 35,997 375,842 10.59 5.00 179,942 1,878,759
2022-11-07 2022-11-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 35,058 339,845 11.50 4.72 165,320 1,602,573
2022-11-07 2022-11-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 104,090 304,787 51.86 4.99 519,107 1,520,003
2022-11-07 2022-11-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 35,058 339,845 11.50 4.72 165,320 1,602,573
2022-11-07 2022-11-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 104,090 304,787 51.86 4.99 519,107 1,520,003
2022-11-07 2022-11-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 35,058 339,845 11.50 4.72 165,320 1,602,573
2022-11-07 2022-11-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 104,090 304,787 51.86 4.99 519,107 1,520,003
2022-10-31 2022-10-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 76,877 200,697 62.09 4.86 373,638 975,428
2022-10-31 2022-10-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 76,877 200,697 62.09 4.86 373,638 975,428
2022-10-31 2022-10-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 76,877 200,697 62.09 4.86 373,638 975,428
2022-10-27 2022-10-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 72,774 123,820 142.57 4.85 353,041 600,676
2022-10-27 2022-10-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 51,046 51,046 4.75 242,387 242,387
2022-10-27 2022-10-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 72,774 123,820 142.57 4.85 353,041 600,676
2022-10-27 2022-10-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 51,046 51,046 4.75 242,387 242,387
2022-10-27 2022-10-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 72,774 123,820 142.57 4.85 353,041 600,676
2022-10-27 2022-10-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 51,046 51,046 4.75 242,387 242,387
2022-06-13 2022-06-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 32,477 90,442 56.03 13.50 438,440 1,220,967
2022-06-13 2022-06-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 951,684 2,650,177 56.03 13.50 12,847,734 35,777,390
2022-06-13 2022-06-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 32,477 90,442 56.03 13.50 438,440 1,220,967
2022-06-13 2022-06-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 951,684 2,650,177 56.03 13.50 12,847,734 35,777,390
2022-06-06 2022-06-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1,129 57,965 1.99 13.03 14,715 755,475
2022-06-06 2022-06-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33,071 1,698,493 1.99 13.03 431,024 22,136,969
2022-06-06 2022-06-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1,129 57,965 1.99 13.03 14,715 755,475
2022-06-06 2022-06-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33,071 1,698,493 1.99 13.03 431,024 22,136,969
2022-06-02 2022-06-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3,036 56,836 5.64 13.45 40,834 764,444
2022-06-02 2022-06-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 88,964 1,665,422 5.64 13.45 1,196,566 22,399,926
2022-06-02 2022-05-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,040 53,800 3.94 13.47 27,470 724,460
2022-06-02 2022-05-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 59,766 1,576,458 3.94 13.47 804,797 21,228,268
2022-06-02 2022-06-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3,036 56,836 5.64 13.45 40,834 764,444
2022-06-02 2022-06-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 88,964 1,665,422 5.64 13.45 1,196,566 22,399,926
2022-06-02 2022-05-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,040 53,800 3.94 13.47 27,470 724,460
2022-06-02 2022-05-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 59,766 1,576,458 3.94 13.47 804,797 21,228,268
2022-05-31 2022-05-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 89 51,760 0.17 13.45 1,197 696,239
2022-05-31 2022-05-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,621 1,516,692 0.17 13.45 35,256 20,401,479
2022-05-31 2022-05-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 667 51,671 1.31 13.49 9,000 697,223
2022-05-31 2022-05-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19,534 1,514,071 1.31 13.49 263,582 20,430,117
2022-05-31 2022-05-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 89 51,760 0.17 13.45 1,197 696,239
2022-05-31 2022-05-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,621 1,516,692 0.17 13.45 35,256 20,401,479
2022-05-31 2022-05-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 667 51,671 1.31 13.49 9,000 697,223
2022-05-31 2022-05-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19,534 1,514,071 1.31 13.49 263,582 20,430,117
2022-05-26 2022-05-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1,429 51,004 2.88 13.43 19,198 685,234
2022-05-26 2022-05-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 41,863 1,494,537 2.88 13.43 562,425 20,078,955
2022-05-26 2022-05-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 588 49,575 1.20 13.37 7,860 662,719
2022-05-26 2022-05-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17,240 1,452,674 1.20 13.37 230,464 19,419,346
2022-05-26 2022-05-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1,429 51,004 2.88 13.43 19,198 685,234
2022-05-26 2022-05-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 41,863 1,494,537 2.88 13.43 562,425 20,078,955
2022-05-26 2022-05-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 588 49,575 1.20 13.37 7,860 662,719
2022-05-26 2022-05-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17,240 1,452,674 1.20 13.37 230,464 19,419,346
2022-05-23 2022-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 628 48,987 1.30 13.48 8,464 660,227
2022-05-23 2022-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 18,406 1,435,434 1.30 13.48 248,069 19,346,205
2022-05-23 2022-05-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 682 48,359 1.43 13.25 9,040 640,984
2022-05-23 2022-05-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19,984 1,417,028 1.43 13.25 264,882 18,782,281
2022-05-23 2022-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 628 48,987 1.30 13.48 8,464 660,227
2022-05-23 2022-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 18,406 1,435,434 1.30 13.48 248,069 19,346,205
2022-05-23 2022-05-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 682 48,359 1.43 13.25 9,040 640,984
2022-05-23 2022-05-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19,984 1,417,028 1.43 13.25 264,882 18,782,281
2022-05-19 2022-05-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,067 47,677 4.53 13.20 27,292 629,522
2022-05-19 2022-05-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 60,583 1,397,044 4.53 13.20 799,932 18,446,429
2022-05-19 2022-05-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,939 45,610 6.89 13.42 39,433 611,954
2022-05-19 2022-05-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 86,110 1,336,461 6.89 13.42 1,155,346 17,931,431
2022-05-19 2022-05-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,067 47,677 4.53 13.20 27,292 629,522
2022-05-19 2022-05-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 60,583 1,397,044 4.53 13.20 799,932 18,446,429
2022-05-19 2022-05-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,939 45,610 6.89 13.42 39,433 611,954
2022-05-19 2022-05-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 86,110 1,336,461 6.89 13.42 1,155,346 17,931,431
2022-05-17 2022-05-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1,094 42,671 2.63 12.90 14,114 550,520
2022-05-17 2022-05-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 32,072 1,250,351 2.63 12.90 413,777 16,131,403
2022-05-17 2022-05-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4,269 41,577 11.44
2022-05-17 2022-05-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 125,096 1,218,279 11.44
2022-05-17 2022-05-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1,094 42,671 2.63 12.90 14,114 550,520
2022-05-17 2022-05-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 32,072 1,250,351 2.63 12.90 413,777 16,131,403
2022-05-17 2022-05-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4,269 41,577 11.44
2022-05-17 2022-05-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 125,096 1,218,279 11.44
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17 37,308 0.05 11.81 201 440,447
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 485 1,093,183 0.04 11.81 5,726 12,905,791
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,728 37,291 7.89 11.62 31,702 433,362
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 79,945 1,092,698 7.89 11.62 929,049 12,698,353
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 88 34,563 0.26 11.85 1,043 409,478
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,564 1,012,753 0.25 11.85 30,376 11,998,389
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,657 34,475 8.35 11.23 29,827 387,009
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 77,866 1,010,189 8.35 11.23 874,108 11,340,180
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17 37,308 0.05 11.81 201 440,447
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 485 1,093,183 0.04 11.81 5,726 12,905,791
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,728 37,291 7.89 11.62 31,702 433,362
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 79,945 1,092,698 7.89 11.62 929,049 12,698,353
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 88 34,563 0.26 11.85 1,043 409,478
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,564 1,012,753 0.25 11.85 30,376 11,998,389
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,657 34,475 8.35 11.23 29,827 387,009
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 77,866 1,010,189 8.35 11.23 874,108 11,340,180
2022-05-11 2022-05-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1,032 31,818 3.35 11.36 11,727 361,567
2022-05-11 2022-05-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30,233 932,323 3.35 11.36 343,556 10,594,546
2022-05-11 2022-05-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,745 30,786 9.79 10.79 29,627 332,270
2022-05-11 2022-05-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 80,430 902,090 9.79 10.79 868,073 9,736,167
2022-05-11 2022-05-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1,032 31,818 3.35 11.36 11,727 361,567
2022-05-11 2022-05-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30,233 932,323 3.35 11.36 343,556 10,594,546
2022-05-11 2022-05-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,745 30,786 9.79 10.79 29,627 332,270
2022-05-11 2022-05-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 80,430 902,090 9.79 10.79 868,073 9,736,167
2022-01-26 2022-01-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19,791 28,041 239.89
2022-01-26 2022-01-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 579,910 821,660 239.88
2022-01-26 2022-01-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8,250 8,250
2022-01-26 2022-01-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 241,750 241,750
2022-01-26 2022-01-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19,791 28,041 239.89
2022-01-26 2022-01-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 579,910 821,660 239.88
2022-01-26 2022-01-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8,250 8,250
2022-01-26 2022-01-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 241,750 241,750
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 7,752 48,406 19.07
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 17,829 139,383 14.67
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 17,829 139,383 14.67
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -49,689 0 -100.00
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 49,689 49,689
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -1,000,000 989,000 -50.28
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 30,347 40,654 294.43
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 111,247 121,554 1,079.33
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 105,874 116,181 1,027.20
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -438,338 0 -100.00
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10,307 10,307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10,307 10,307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10,307 10,307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 438,338 438,338
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -2,000,000 1,394,333 -58.92
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 7,752 48,406 19.07
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 17,829 139,383 14.67
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 17,829 139,383 14.67
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -49,689 0 -100.00
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 49,689 49,689
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -1,000,000 989,000 -50.28
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 30,347 40,654 294.43
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 111,247 121,554 1,079.33
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 105,874 116,181 1,027.20
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -438,338 0 -100.00
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10,307 10,307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10,307 10,307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10,307 10,307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 438,338 438,338
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -2,000,000 1,394,333 -58.92
2021-02-19 2021-02-17 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
S - Sale -10,000 99,155 -9.16 36.95 -369,503 3,663,807
2021-02-19 2021-02-17 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
S - Sale -10,000 99,155 -9.16 36.95 -369,503 3,663,807
2020-12-16 2020-12-14 4 CNST CONSTELLATION PHARMACEUTICALS INC
Warrant (right to buy)
X - Other -30,107 0 -100.00
2020-12-16 2020-12-14 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
X - Other 30,107 2,584,957 1.18 1.55 46,666 4,006,683
2020-12-16 2020-12-14 4 CNST CONSTELLATION PHARMACEUTICALS INC
Warrant (right to buy)
X - Other -30,107 0 -100.00
2020-12-16 2020-12-14 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
X - Other 30,107 2,584,957 1.18 1.55 46,666 4,006,683
2020-09-03 2020-09-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 27,595 1,827,025 1.53 17.67 487,604 32,283,532
2020-09-03 2020-09-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 36,494 1,799,430 2.07 17.64 643,754 31,741,945
2020-09-03 2020-09-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 27,595 1,827,025 1.53 17.67 487,604 32,283,532
2020-09-03 2020-09-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 36,494 1,799,430 2.07 17.64 643,754 31,741,945
2020-08-31 2020-08-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 26,135 1,762,936 1.50 17.89 467,555 31,538,925
2020-08-31 2020-08-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 36,359 1,736,801 2.14 17.79 646,827 30,897,690
2020-08-31 2020-08-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 26,135 1,762,936 1.50 17.89 467,555 31,538,925
2020-08-31 2020-08-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 36,359 1,736,801 2.14 17.79 646,827 30,897,690
2020-08-25 2020-08-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 100 1,700,442 0.01 18.00 1,800 30,607,956
2020-08-25 2020-08-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 11,024 1,700,342 0.65 17.96 197,991 30,538,142
2020-08-25 2020-08-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7,321 1,689,318 0.44 17.97 131,558 30,357,044
2020-08-25 2020-08-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 100 1,700,442 0.01 18.00 1,800 30,607,956
2020-08-25 2020-08-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 11,024 1,700,342 0.65 17.96 197,991 30,538,142
2020-08-25 2020-08-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7,321 1,689,318 0.44 17.97 131,558 30,357,044
2020-08-17 2020-08-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 6,425 1,681,997 0.38 17.89 114,943 30,090,926
2020-08-17 2020-08-14 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37,993 1,675,572 2.32 17.49 664,498 29,305,754
2020-08-17 2020-08-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19,895 1,637,579 1.23 17.89 355,922 29,296,288
2020-08-17 2020-08-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 6,425 1,681,997 0.38 17.89 114,943 30,090,926
2020-08-17 2020-08-14 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37,993 1,675,572 2.32 17.49 664,498 29,305,754
2020-08-17 2020-08-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19,895 1,637,579 1.23 17.89 355,922 29,296,288
2020-08-03 2020-07-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 732 1,617,684 0.05 17.99 13,169 29,102,135
2020-08-03 2020-07-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 732 1,617,684 0.05 17.99 13,169 29,102,135
2020-07-30 2020-07-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4,105 1,616,952 0.25 17.99 73,849 29,088,966
2020-07-30 2020-07-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4,105 1,616,952 0.25 17.99 73,849 29,088,966
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series D Preferred Stock
C - Conversion -686,274 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series D Preferred Stock
C - Conversion -686,274 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -1,989,000 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -1,836,000 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series A-2 Preferred Stock
C - Conversion -875,000 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series A-1 Preferred Stock
C - Conversion -600,000 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 686,274 686,274
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 686,274 686,274
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 1,989,000 1,989,000
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 1,836,000 3,394,333 117.82
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 875,000 1,558,333 128.05
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 600,000 683,333 720.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series D Preferred Stock
C - Conversion -686,274 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series D Preferred Stock
C - Conversion -686,274 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -1,989,000 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -1,836,000 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series A-2 Preferred Stock
C - Conversion -875,000 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series A-1 Preferred Stock
C - Conversion -600,000 0 -100.00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 686,274 686,274
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 686,274 686,274
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 1,989,000 1,989,000
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 1,836,000 3,394,333 117.82
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 875,000 1,558,333 128.05
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 600,000 683,333 720.00
2020-07-28 2020-07-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3,834 1,612,847 0.24 17.99 68,974 29,015,118
2020-07-28 2020-07-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 68,749 1,609,013 4.46 17.93 1,232,670 28,849,603
2020-07-28 2020-07-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3,834 1,612,847 0.24 17.99 68,974 29,015,118
2020-07-28 2020-07-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 68,749 1,609,013 4.46 17.93 1,232,670 28,849,603
2020-07-23 2020-07-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 193 1,540,264 0.01 18.00 3,474 27,724,752
2020-07-23 2020-07-21 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -24,000 0 -100.00
2020-07-23 2020-07-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
M - Exercise 24,000 44,000 120.00 13.35 320,400 587,400
2020-07-23 2020-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 16,806 16,806
2020-07-23 2019-05-15 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 24,000 24,000
2020-07-23 2019-05-15 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 24,000 24,000
2020-07-23 2020-07-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 193 1,540,264 0.01 18.00 3,474 27,724,752
2020-07-23 2020-07-21 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -24,000 0 -100.00
2020-07-23 2020-07-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
M - Exercise 24,000 44,000 120.00 13.35 320,400 587,400
2020-07-23 2020-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 16,806 16,806
2020-07-23 2019-05-15 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 24,000 24,000
2020-07-23 2019-05-15 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 24,000 24,000
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166,666
2020-04-09 2020-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 112,602 1,540,071 7.89 14.95 1,683,400 23,024,061
2020-04-09 2020-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 112,602 1,540,071 7.89 14.95 1,683,400 23,024,061
2020-04-07 2020-04-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 123,728 1,427,469 9.49 14.38 1,779,209 20,527,004
2020-04-07 2020-04-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14,587 1,303,741 1.13 12.41 181,025 16,179,426
2020-04-07 2020-04-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 123,728 1,427,469 9.49 14.38 1,779,209 20,527,004
2020-04-07 2020-04-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14,587 1,303,741 1.13 12.41 181,025 16,179,426
2020-04-02 2020-04-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14,850 1,289,154 1.17 12.40 184,140 15,985,510
2020-04-02 2020-04-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 118,067 1,274,304 10.21 12.26 1,447,501 15,622,967
2020-04-02 2020-03-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 118,067 1,156,237 11.37 12.53 1,479,380 14,487,650
2020-04-02 2020-04-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14,850 1,289,154 1.17 12.40 184,140 15,985,510
2020-04-02 2020-04-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 118,067 1,274,304 10.21 12.26 1,447,501 15,622,967
2020-04-02 2020-03-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 118,067 1,156,237 11.37 12.53 1,479,380 14,487,650
2020-03-25 2020-03-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,416 1,038,170 0.23 12.49 30,176 12,966,743
2020-03-25 2020-03-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 128,377 1,035,754 14.15 12.22 1,568,767 12,656,914
2020-03-25 2020-03-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 170,387 907,377 23.12 11.63 1,981,601 10,552,795
2020-03-25 2020-03-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,416 1,038,170 0.23 12.49 30,176 12,966,743
2020-03-25 2020-03-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 128,377 1,035,754 14.15 12.22 1,568,767 12,656,914
2020-03-25 2020-03-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 170,387 907,377 23.12 11.63 1,981,601 10,552,795
2020-03-23 2020-03-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 143,082 736,990 24.09 11.77 1,684,075 8,674,372
2020-03-23 2020-03-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 148,464 593,908 33.33 11.59 1,720,698 6,883,394
2020-03-23 2020-03-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 143,082 736,990 24.09 11.77 1,684,075 8,674,372
2020-03-23 2020-03-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 148,464 593,908 33.33 11.59 1,720,698 6,883,394
2020-03-23 2020-03-20 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 5,539 6,051,376 0.09 23.15 128,228 140,089,354
2020-03-23 2020-03-19 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 36,135 6,045,837 0.60 22.38 808,701 135,305,832
2020-03-23 2020-03-20 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 5,539 6,051,376 0.09 23.15 128,228 140,089,354
2020-03-23 2020-03-19 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 36,135 6,045,837 0.60 22.38 808,701 135,305,832
2020-03-06 2020-03-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8,307 445,444 1.90 18.00 149,526 8,017,992
2020-03-06 2020-03-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8,307 445,444 1.90 18.00 149,526 8,017,992
2020-03-04 2020-03-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 9,986 437,137 2.34 17.96 179,349 7,850,981
2020-03-04 2020-03-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 38,758 427,151 9.98 17.99 697,256 7,684,446
2020-03-04 2020-03-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14,124 388,393 3.77 17.90 252,820 6,952,235
2020-03-04 2020-03-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 9,986 437,137 2.34 17.96 179,349 7,850,981
2020-03-04 2020-03-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 38,758 427,151 9.98 17.99 697,256 7,684,446
2020-03-04 2020-03-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14,124 388,393 3.77 17.90 252,820 6,952,235
2020-02-28 2020-02-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37,800 374,269 11.23 17.91 676,998 6,703,158
2020-02-28 2020-02-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33,896 336,469 11.20 17.91 607,077 6,026,160
2020-02-28 2020-02-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3,751 302,573 1.26 18.00 67,518 5,446,314
2020-02-28 2020-02-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37,800 374,269 11.23 17.91 676,998 6,703,158
2020-02-28 2020-02-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33,896 336,469 11.20 17.91 607,077 6,026,160
2020-02-28 2020-02-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3,751 302,573 1.26 18.00 67,518 5,446,314
2020-02-10 2020-02-06 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 44,900 298,822 17.68 15.96 716,604 4,769,199
2020-02-10 2020-02-06 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 44,900 298,822 17.68 15.96 716,604 4,769,199
2019-11-13 2019-11-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 15 253,922 0.01 12.00 180 3,047,064
2019-11-13 2019-11-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 15 253,922 0.01 12.00 180 3,047,064
2019-11-06 2019-11-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8,409 253,907 3.43 11.99 100,824 3,044,345
2019-11-06 2019-11-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8,409 253,907 3.43 11.99 100,824 3,044,345
2019-10-24 2019-10-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,087 245,498 0.86 11.86 24,752 2,911,606
2019-10-24 2019-10-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,300 243,411 0.95 12.00 27,600 2,920,932
2019-10-24 2019-10-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,087 245,498 0.86 11.86 24,752 2,911,606
2019-10-24 2019-10-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,300 243,411 0.95 12.00 27,600 2,920,932
2019-10-21 2019-10-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 43,400 241,111 21.95 11.94 518,196 2,878,865
2019-10-21 2019-10-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34,721 197,711 21.30 11.29 392,000 2,232,157
2019-10-21 2019-10-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 6,818 162,990 4.37 10.62 72,407 1,730,954
2019-10-21 2019-10-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 43,400 241,111 21.95 11.94 518,196 2,878,865
2019-10-21 2019-10-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34,721 197,711 21.30 11.29 392,000 2,232,157
2019-10-21 2019-10-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 6,818 162,990 4.37 10.62 72,407 1,730,954
2019-10-16 2019-10-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34,900 156,172 28.78 10.26 358,074 1,602,325
2019-10-16 2019-10-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33,200 121,272 37.70 10.31 342,292 1,250,314
2019-10-16 2019-10-14 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34,900 88,072 65.64 10.36 361,564 912,426
2019-10-16 2019-10-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34,900 156,172 28.78 10.26 358,074 1,602,325
2019-10-16 2019-10-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33,200 121,272 37.70 10.31 342,292 1,250,314
2019-10-16 2019-10-14 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34,900 88,072 65.64 10.36 361,564 912,426
2019-10-11 2019-10-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17,724 53,172 50.00 10.57 187,343 562,028
2019-10-11 2019-10-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17,724 35,448 100.00 10.50 186,102 372,204
2019-10-11 2019-10-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17,724 17,724 10.26 181,848 181,848
2019-10-11 2019-10-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17,724 53,172 50.00 10.57 187,343 562,028
2019-10-11 2019-10-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17,724 35,448 100.00 10.50 186,102 372,204
2019-10-11 2019-10-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17,724 17,724 10.26 181,848 181,848
2019-10-07 2019-10-03 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 80,000 159,155 101.07 8.50 680,000 1,352,818
2019-10-07 2019-10-03 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 1,331,764 6,009,702 28.47 8.50 11,319,994 51,082,467
2019-08-09 2019-08-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 152 2,597,816 0.01 13.99 2,126 36,343,446
2019-08-09 2019-08-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12 2,597,664 0.00 13.98 168 36,315,343
2019-08-09 2019-08-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 224,500 2,597,652 9.46 14.00 3,143,000 36,367,128
2019-08-07 2019-08-06 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 310 2,373,152 0.01 13.96 4,328 33,129,202
2019-08-07 2019-08-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5,824 2,372,842 0.25 13.98 81,400 33,164,263
2019-08-05 2019-08-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1,782 2,367,018 0.08 13.97 24,898 33,072,212
2019-08-05 2019-08-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2,600 2,365,236 0.11 13.98 36,346 33,064,107
2019-07-31 2019-07-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8,855 2,362,636 0.38 13.91 123,195 32,870,173
2019-07-31 2019-07-29 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19,201 2,353,781 0.82 13.58 260,727 31,961,521
2019-07-26 2019-07-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30,059 2,334,580 1.30 13.59 408,634 31,737,214
2019-07-26 2019-07-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30,753 2,304,521 1.35 13.37 411,294 30,820,894
2019-07-26 2019-07-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 29,054 2,273,768 1.29 13.51 392,502 30,717,241
2019-07-23 2019-07-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30,760 2,244,714 1.39 13.35 410,535 29,958,851
2019-07-23 2019-07-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30,760 2,213,954 1.41 13.54 416,337 29,965,867
2019-07-23 2019-07-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 6,222 2,183,194 0.29 13.99 87,043 30,541,792
2019-07-17 2019-07-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3,900 2,176,972 0.18 13.86 54,055 30,173,485
2019-07-17 2019-07-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 16,188 2,173,072 0.75 13.69 221,547 29,740,446
2019-07-15 2019-07-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 21,014 2,156,884 0.98 13.88 291,765 29,946,825
2019-07-15 2019-07-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 10,870 2,135,870 0.51 13.87 150,752 29,621,527
2019-06-26 2019-06-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12,240 2,125,000 0.58 13.78 168,650 29,279,525
2019-06-21 2019-06-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3,763 2,112,760 0.18 14.03 52,789 29,638,854
2019-06-21 2019-06-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 15,400 2,108,997 0.74 13.86 213,385 29,222,684
2019-06-21 2019-06-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 15,214 2,093,597 0.73 13.91 211,674 29,128,424
2019-06-14 2019-06-14 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 10,760 2,078,383 0.52 14.00 150,687 29,106,507
2019-06-14 2019-06-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 11,500 2,067,623 0.56 14.13 162,508 29,217,787
2019-06-14 2019-06-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7,500 2,056,123 0.37 14.00 104,989 28,782,638
2019-06-11 2019-06-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 10,900 2,048,623 0.53 13.83 150,718 28,326,925
2019-06-11 2019-06-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12,600 2,037,723 0.62 13.66 172,176 27,845,077
2019-06-06 2019-06-06 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12,600 2,025,123 0.63 13.40 168,884 27,143,736
2019-06-06 2019-06-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12,600 2,012,523 0.63 13.39 168,764 26,955,733
2019-05-22 2019-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 50,000 1,999,923 2.56 13.50 675,000 26,998,960
2019-05-13 2019-05-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17,923 1,949,923 0.93 13.85 248,234 27,006,434
2019-05-09 2019-05-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 57,000 1,932,000 3.04 14.10 803,700 27,241,200
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -3,400,000 0 -100.00
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion -2,377,334 0 -100.00
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -8,408,933 0 -100.00
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -12,000,000 0 -100.00
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 15,000 15,000 16.00 240,000 240,000
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1,875,000 1,875,000 16.00 30,000,000 30,000,000
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 13,093,134 13,569,091 2,750.91
2019-04-03 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
951,914
2019-04-03 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
951,914
2019-04-03 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
951,914
2019-04-03 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
951,914
2019-04-03 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
951,914
2019-04-03 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
951,914
2019-04-03 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
951,914
2019-04-02 2019-04-02 4 IMDZ IMMUNE DESIGN CORP.
Common Stock
U - Other -6,642,942 0 -100.00 5.85 -38,861,211
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series F Preferred Stock
C - Conversion -300,000 0 -100.00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series F Preferred Stock
C - Conversion -20,000,000 0 -100.00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series E-1 Preferred Stock
C - Conversion -6,502,856 0 -100.00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series E Preferred Stock
C - Conversion -444,444 0 -100.00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series E Preferred Stock
C - Conversion -3,555,555 0 -100.00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -970,159 0 -100.00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -8,333,333 0 -100.00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -11,000,000 0 -100.00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
C - Conversion 79,155 79,155
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
C - Conversion 4,666,888 4,677,939 42,230.46
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22,102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22,102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22,102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22,102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22,102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22,102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22,102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22,102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22,102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22,102
2017-10-30 2017-10-27 4 IMDZ Immune Design Corp.
Common Stock
P - Purchase 2,681,000 6,642,942 67.67 4.10 10,992,100 27,236,062
2016-09-22 2016-09-20 4 IMDZ Immune Design Corp.
Common Stock
P - Purchase 800,000 3,961,942 25.30 6.25 5,000,000 24,762,138
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock
C - Conversion -428,134 0 -100.00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock
X - Other 428,134 428,134
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock Warrant (right to buy)
X - Other -428,134 0 -100.00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock
C - Conversion -856,269 0 -100.00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series B Preferred Stock
C - Conversion -744,580 0 -100.00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series A Preferred Stock
C - Conversion -733,943 0 -100.00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
P - Purchase 399,016 3,161,942 14.44 12.00 4,788,192 37,943,304
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 428,134 2,762,926 18.34
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 856,269 2,334,792 57.91
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 744,580 1,478,523 101.45
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 733,943 733,943
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)